During the past decade, Shin Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shin Clinic" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Medical Research Council Population Health Research Unit, CTSU, University of Oxford (academic lead)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Shin Clinic" are "Chronic Kidney Disease" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Shin Clinic" in a lesser frequency.

Most popular intervention types in "Shin Clinic" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Empagliflozin" (2 trials), "Matching placebo" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shin Clinic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Shin Clinic". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Shin Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shin Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".